Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03133481 · ClinicalTrials.gov registry record · Phase 3
Adductor Canal Block Versus Femoral Nerve Block for Total Knee Arthroplasty
A Phase 3 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 3
- Development phase
- 94
- Enrollment target
NCT03133481 is a Phase 3 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 94 participants.
The verdict
NCT03133481, a Phase 3 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 94 participants
- Enrollment target
Study Summary
Peripheral nerve blocks catheters of the femoral nerve have long been used for perioperative analgesia in total knee arthroplasty (TKA). These blocks provide effective analgesia and patient satisfaction for surgical pain relief. However, one of the main drawbacks to the femoral nerve block (FNB) is a denser motor block of the quadriceps muscle that can delay aggressive physical therapy and subsequent recovery from surgery. (1) Recently, there has been increasing interest in performing adductor canal blocks (ACB) with the aim of less motor blockade while providing commensurate analgesia compared to the FNB. (1,2) Current investigative reports have provided only preliminary data, and there is potential to change the standard of care for TKA as more data mounts in favor of ACBs. The goal of this study is to verify the analgesic equivalence of the two blocks, compare patient satisfaction, surgeon satisfaction, and physical therapy grading between the two blocks. Potentially, this would change the standard of care for TKA patients at this institution.
Interventions
- PROCEDURE Adductor Canal Nerve Block
- DRUG Femoral Nerve Block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2014-10-22 |
| Est. Completion | 2019-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03133481
The ClinicalTrials.gov registry entry for NCT03133481 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 94 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Adductor Canal Nerve Block is the first listed.
NCT03133481 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03133481 about?
NCT03133481 is a clinical study titled "Adductor Canal Block Versus Femoral Nerve Block for Total Knee Arthroplasty". Peripheral nerve blocks catheters of the femoral nerve have long been used for perioperative analgesia in total knee arthroplasty (TKA). These blocks provide effective analgesia and patient satisfaction for surgical pain relief. However, one of the main drawbacks to the femoral nerve block (FNB) is ...
What is the current status of trial NCT03133481?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 94 participants. The study started on 2014-10-22. Estimated completion is 2019-01.
What interventions are being tested in trial NCT03133481?
The interventions under investigation include: Adductor Canal Nerve Block (PROCEDURE), Femoral Nerve Block (DRUG).
Who is sponsoring clinical trial NCT03133481?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.